Review of Available Data on the Growth Rate of Human Tumours THE sparsity of data on the growth rate of human tumours is the result of two principal limitations. Firstly, the number of sites in the body at which more than one measurement of tumour volume can normally be made is strictly limited to two classes of tumours, those which occur superficially and are therefore accessible to direct measurement and those which can be clearly defined on a radiograph. The second limitation is on the number of cases in which it is justifiable to withold treatment during the observation period. Mainly as a result ofthese two constraints those data which have been reported are subject to a high degree of selection. and this factor must be borne in mind whenever inferences are made about the general behaviour of cancer in man. To emphasise this point, the available data will be classified by tumour site for the purpose of this review. In comparing the work of different authors the parameter of tumour volume doubling time will be used, since this has been the custom in most of the published literature. Doubling time has the advantage over other parameters such as " exponential growth constant " (Spratt and Spratt, 1964) that it allows one easily to form a mental image of the rate of growth of a tumour. Provided that the data allow reliable tumour volumes to be estimated, this parameter is also preferable to values of rate of growth of tumour diameter because on tumours of widely different sizes it indicates the specific rate of expansion. However, doubling time is a parameter which is only rigorously applicable to pure exponential curves. Its use in the context of human tumour growth curves, where the quality of the data always leaves some uncertainty about the precise equation of growth, is on the following definition: the doubling time of a tumour is the doubling time of the exponential which, on a semilogarithmic plot, is a tangent to the growth curve at the point of interest.
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Comparions between authors involve comparison of distributions of tumour doubling time in different series of cases. For the purpose of this review the limits of the range will be quoted, together with the median doubling time (the inid-point of a list ranged in order of increasing doubling time).
(i) Tumour metastases observed in the lung
The greatest amount of published data is available for metastatic deposits in the lung, on account of the ease with which the tumour outline may often be seen radiographically. Selection exists here also, however, for only in certain regions of the thorax can a clear shadow be traced. The practicability and tlle significance of the measurement of lung metastases was stressed by Collins. Loeffler and Tivey (1956) Garland, Coulson and Wollin (1963) reported growth data on 41 cases of primary lung tumours. For most of these cases only two or three serial measurements were obtained and the data do not allow any conclusion to be drawn about the shape of the tumour growth curve. The observed tumour doubling times ranged from 27 to 500 days with a median of 90 days. Classification of tumours by histological type showed no significant difference in growth rate. Spratt, Spjut and Roper (1963) also attempted to find statistical differences between the growth rates of primary lung tumours of various histological types. In a series of 22 cases they demonstrated significant differences between variances of the growth rates of adenocarcinoma, epidermoid carcinoma and undifferentiated carcinoma, but could not conclude anything about the differences in the mean rates of growth. Despite the fact that these authors were not on the basis of their data "76 able to distinguish between exponential and " cube root " growth curves, they nevertheless computed estimated durations for exponential growth from the size of a single cell.
(iii) Tumours in other sites
Bone tumours form another class of neoplasm in which the primary growth is amenable to accurate localisation on a radiograph. Spratt (1965) examined a series of 8 primary osteogenic tumours. These were reported to have doubling times which fell into two groups, one around 25 days, the other in excess of 128 days, these groups cutting across the histological classification. With such an unusual distribution of doubling times, any measure of central tendency is of doubtful value; Spratt quotes a geometric mean of 36 days. Growth curves are given, but the portions of these which refer to untreated tumours are so small that no conclusions can be drawn about the shape of the tumour growth curves; for the same reason the precision of the doubling time measurements is difficult to judge.
The work of Welin, Youker and Spratt (1963) has provided valuable data on the growth rate of primary tumours of the colon and rectum. Using a carefully designed (" double contrast enema ") technique they claimed to be able to detect lesions as small as 3 mm. in diameter and that their total margin of error was only ± 2 mm. on the measurement of a diameter. Their justification for this claim is, however, not clear. Tumours in this anatomical site commonlv occur as circumferentially spreading plaques and the tumour volume was therefore calculated by assuming the tumour to be cylindrical in shape. Even allowing for the uncertainty in volume which clearly exists here, there is no doubt that the rate of growtlh of tumours in this series (375 tumours in all) is considerably slower than for other tumours on which growth measurements have been made. The authors conclude that most malignant tumours in this site had doubling times in the range 138 to 1155 days although in some cases no growth was detected. They also concluded, despite the precision which they claim for their measurement of tumour diameter, that it was impossible to distinguish between linear and exponential growth curves. There seems to be no doubt that for tumours of the colon and rectum the primary growth has on the average a distinctly slower rate of growth than its pulmonary metastases: Spratt (1965) Gompertz equatioin, which has the characteristic of a doubling time which increases with an exponential function of time. The exponential growth curve is the limiting case of both these treatments, and it is usually best approximated by tumours in the earlier part of their observed growth period.
With this background, it is difficult to expect any different situation in humain tumour growth, the more so because the tumours measured in radiographic survevs have been relatively large, often in the range 1 to 100 grams in weight. Spratt (1965) argues that we do not know at what size human tumours might be expected to depart from exponential growth. It could be that the departures found in the experimental animal tumours to some extent occur because the tumours reach a significant proportion of the host body weight. If this were an important factor, then one might expect tumours in man to grow exponentially to a muclh larger absolute size. However, whilst one would expect a deviation from exponential when the tumour begins to become a major drain on the metabolic resources of the host, one would also expect a deviation at a point which is dependent on absolute tumour size. The growth rate of a tumour depends on the inherent proliferative capacity of well-vascularised tumour tissue but also on the proportion of the tumour which is well-vascularised. The work of Thomlinson and Gray (1955) emphasised the importance of the capillary system in the growth of tumours and showed that cell proliferation would not be expected beyond about 150 micronis from a capillary. When an exponentially-growing tumour is small the conditioni of satisfactory vascularisation may be attained but, as it grows, vascular accidents may lead to central necrosis and furthermore, since the perimeter of the tumour is also growing exponentially, it may become increasingly difficult for the proliferation of capillaries near the surface of the tumour to keep up with the volume inerease. From both of these points of view an upper limit on the size which a tumour can reaclh by exponential growth is to be expected. This upper limit will depend on tumour growth rate but in any partially-necrotic tumour it could be assumed that the limit has been passed and that the tumour has already begun to grow more slowly.
In view of these considerations, little support can be given to the suggestion sometimes made that the point of departure from assumed exponential growth might be proportional to the body weight of the host and that if tumours in the rat generally deviate from exponential growth at about 1 gram in size (Fig. 1) T'he Feasibility of Predicting Times of Induction from the Growth Curves of Human Tumnour8 In the literature on humain tumour growth it has been a widespread practice, on finding a growth curve which approximates to an exponential, to extrapolate this back to the initial size of a small clone of cells in the hope that the time intercept may indicate the time at which tumour induction was completed. Since a detectable humain tumour contains in the region of 109-1010 cells, the extrapolation must be over about nine orders of mangitude of tumour size and it is immediately clear that this must involve considerable uncertainty.
In the paper of Collins et al. (1956) the authors clearly emphasised the fact that if exponential growth over the whole life of a tumour can be assumed, then the preclinical period must greatly exceed the period from first symptoms to death of the host. They also stressed the facts that the apparently sudden appearance of a rapidly-growing lump may not be inconsistent with regular exponential growth, and that the absence of detectable lung metastases should not be taken to mean that microscopic growths may not be present. The procedure of exponential extrapolation can also be applied to predict possible times of recurrence, and Collins and his co-workers were able to show that for a series of 206 children with Wilms' tumour the risk of recurrence agreed well with theoretical prediction by the methodof Boag (1949) and also were consistent with predictions on the basis of exponential growth.
Subsequent authors (see Schwartz, 1961) have reiterated the theory of exponential growth without adding greatly to it; others have merely used the theory to predict the total " duration " of tumours. It has usually been assumed that the precision of such estimates is sufficiently good to be worthwhile and it is therefore necessary to discuss the uncertainties which are involved. Fig. 2 . Bearing in mind the limited precision of measurements on human tumours and the relatively small range of tumour size on which they are usually made, one can judge from Fig. 2 the degree of certainty with which one could establish the equation of growth in a particular case. One might expect to be easily able to distinguish linear growth from exponential growth (though this has been doubted by Welin et al. (1963) for their work on primary tumours of the colon) but it is clear that an uncertainty of 10% or even 30% in b would not be surprising. The backward extrapolation of these curves is shown in Fig. 3 . For small values of b the curves approach asymptotically a time intercept which is shorter than the silent interval obtained by exponential extrapolation. Fig. 4 shows the time within which the curves rise from 10-9 gram to the point of initial detection. For most values of b the extrapolated curves come down so steeply that at some point the volume doubling time falls below a value of 10 hours. Since this approximates to the shortest cell cycle time found in mammalian systems any shorter doubling time must be regarded as being unbiological. This is indicated in Fig. 4 but it remains that for values of b close to unity, the predictions are reasonable, and it can be seen that in this region the extrapolated silent interval is changing very rapidly with b-value. An uncertainty of 10% in b may thus affect the silent interval by a factor of two. It is not claimed that tumours do follow solutions to the Mendelsohn equation, only that on the basis of the present data one cannot say that they do not. The limit of error could in fact be greater than that predicted on this basis.
It is clear therefore that any slight deviations from exponential in tumour growth curves can give rise to large errors in estimates of silent interval. This discussion has, however, been concerned purely with the mathematical aspects of possible error. Very relevant also to the validity of exponential extrapolation are the concepts of tumour progression and the choice between the hypotheses of Inherent Slow Growth and Restricted Slow Growth outlined above. Tumour progression (Foulds, 1956 ) is now a widely accepted concept and it would lead one to expect a decreasing volume doubling time as those cells or cell lines which have the shortest cell cycle time and the greatest resistance to host defences gradually outgrow the rest of the tumour cell population. Restriction of growth implies an increasing volume doubling time, and therefore from a purely biological point of view one might expect the full growth curve for a tumour to be sigmoid in shape when plotted seinilogarithmically. It is conceivable that in some particularcase extrapolation back of the terminal portion of a growth curve could in fact indicate the true time of induction, purely by a coincidental combination of early progression and late restriction. Whilst in the published literature on the growth of human tumours extrapolation has always been by an assumed exponential curve, the availability of more complete data on experimental tumours enables one in principle to make a more sophisticated extrapolation. This has been done by Laird (1964 Laird ( , 1965 The Contribution from Studie8 of Cell Proliferation in Tumours Many of the problems in our understanding of the overall growth of tumours arise out of ignorance of the basic characteristics ofthe proliferating cell population, despite the fact that techniques of investigation of cell population kinetics have been developing rapidly over the past ten years (Wimber, 1963) . The application of these techniques to experimental tumours has been shown to be feasible and data are now available on a variety of tumour types (Mendelsohn, Dohan and Moore, 1960; Mendelsohn, 1960 Mendelsohn, , 1962 Bertalanffy and Lau, 1962; Bertalanffy, 1963; Edwards et al., 1960) .
The problem of measuring cell production rate in a tumour is essentially the same as in normnal tissues. The basic concept is that of the distribution of cell cycle time : individual cells will have cell cycle (intermitotic) times varying from a minimum value of perhaps 10 hours up to indefinitely long values in the case of cells which for some reason cease to divide. In rapidly-proliferating normal tissues such as intestinal epithelium (Cairnie, Lamerton and Steel, 1965 ) the distribution of cell cycle times may be quite narrow but in any tumour in which there is a vascular limitation on the size of the proliferating cell population one might expect a rather broad distribution, with many cells not dividing at all. It was on this basis that Mendelsohn (1962) definition of the boundary between proliferation and non-proliferation but when this can be decided the experimentally difficult problem of determining the distribution of cell cycle times and hence the cell production rate can be reduced to the measurement of two parameters: (i) the growth fraction
(ii) the mean cycle time of proliferating cells.
'I'hus slow tumour growth could be the result of a long cell cycle time with a large growth fraction, or a short cell cycle time coupled with a small growth fraction. The first problem in the study of cell proliferation in tumours is to be able to decide between these two alternatives.
As regards cell proliferation in human tumours, the experimental difficulties are very great. However, in the light of a detailed knowledge of the situation in experimental tumours it may be possible to plan simple investigations yielding the maximum amount of information. Apart from mitotic index, the only parameter of cell proliferation which has so far been determined in human material is a thymidine labelling index. Occasionally this has been obtained by in vivo labelling (Johnson, Rubini, Cronkite and Bond, 1960;  Clarkson, Ota and Karnofsky, 1962) but nmore commonly in vitro labelling techniques have been used (Johnson and Bond, 1961; WAolberg and Brown, 1962 ; Oehlert, D6rmer and Lesch, 1963; Reid, 1964; Titus and Shorter, 1965; Steel and Bensted, 1965) . Despite the considerable amount of work which has been done in this direction, little attempt has been made quantitatively to interpret thymidine 1abelling index. There are difficulties in this, but a possible approach has been suggested by Steel and Bensted (1965) 
CONCLUSIONS
It is difficult to avoid the conclusion that much ofthe discussion in the literature of the exponential growth of human tumours and the duration ofthe " silent interval " has been based on insufficient evidence. It may well be that under certain circumstances the exponential extrapolation of a growth curve does yield valid results. However, the present examination of the literature has indicated that this need not be the case, but that errors of a factor of two or more in the estimate of silent interval may be expected.
Other aspects of the growth of human tumours are more deserving of the attentioII of investigators. The remarkably slow growth of many neoplasms is yet to be explained. Is this inherent in the cell proliferation of well-nourished tumour tissue or is it the result of restrictions imposed by the vascular system of the tumour? It would be well if the emphasis on the silent interval should lead to detailed experimental studies of the growth of microscopic tumours and a fuller understanding of the factors which determine the time between induction and the onset of symptoms. It is through an attack on such problems as these that we may hope to gain some control over the growth rate of human tumours, perhaps even to persuade some of them to grow more slowly and hence to make them less unpleasant to live with.
SUMMARY
Published literature on the growth rate of tumours in man is reviewed with particular reference to work which gives significant information on the form of human tumour growth curves. Only in tumours of the lung is the data sufficiently good to make any deductions about the equation of growth; in this situation the growth curves seem to be predominantly exponential.
The widespread practice of extrapolating assumed growth curves back to deduce the time of induction is examined. It is shown that slight deviations from exponential might produce errors of a factor of two or more in the predicted length of the preclinical period. In addition the unpredictable effect of tumour progression complicates the situation still further. The need is for experimental evidence on the growth rate of microscopic tumours.
The occurrence of slow exponential growth in large lung metastases could either be the result of an inherent propertv of well-vascularised tumour tissue or the statistical result of tumour growth being restricted, probably under vascular limitations. The importance of studies of cell proliferation in deciding between these two hypotheses is stressed.
